The estimated Net Worth of Claudia Grimaldi is at least $972 Tysiąc dollars as of 13 March 2024. Ms. Grimaldi owns over 336,666 units of IGC Pharma Inc stock worth over $388,414 and over the last 6 years she sold IGC stock worth over $287,040. In addition, she makes $296,783 as Vice President i Principal Financial Officer at IGC Pharma Inc.
Claudia has made over 5 trades of the IGC Pharma Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she exercised 336,666 units of IGC stock worth $126,081 on 13 March 2024.
The largest trade she's ever made was exercising 336,666 units of IGC Pharma Inc stock on 13 March 2024 worth over $126,081. On average, Claudia trades about 109,312 units every 289 days since 2018. As of 13 March 2024 she still owns at least 1,037,154 units of IGC Pharma Inc stock.
You can see the complete history of Ms. Grimaldi stock trades at the bottom of the page.
Claudia Grimaldi serves as Vice President, Principal Financial Officer of the Company. She is responsible for managing the accounting and finance staff in various countries and is responsible for ensuring timely and accurate statutory and regulatory compliance (SEC, FINRA, NYSE, IRS, XETRA 2, among others). She has almost ten years of experience with the Company and about eight years of experience with SEC filings, regulatory compliance, and disclosures, having held increasing responsibilities first as Manager of financial reporting and compliance from May 2011 to 2013 and then as then as General Manager financial reporting and compliance from 2013 to May 2018. She also serves as a Director/Manager for some of our subsidiaries. Ms. Grimaldi graduated summa cum laude from Javeriana University, a top five university in Colombia, with a Bachelor of Arts in Psychology. She holds an MBA in General Management, graduating with Highest Honors, from Meredith College, in North Carolina. She is a member of Delta Mu Delta International Honor Society. In addition, she has attended the Darden School of Business Financial Management Executives program at the University of Virginia, and SEC reporting and compliance seminars. She is also fluent in both English and Spanish.
As the Vice President i Principal Financial Officer of IGC Pharma Inc, the total compensation of Claudia Grimaldi at IGC Pharma Inc is $296,783. There are 1 executives at IGC Pharma Inc getting paid more, with Ram Mukunda having the highest compensation of $801,000.
Claudia Grimaldi is 48, she's been the Vice President i Principal Financial Officer of IGC Pharma Inc since 2018. There are 4 older and 2 younger executives at IGC Pharma Inc. The oldest executive at IGC Pharma Inc is Richard Prins, 62, who is the Independent Chairman of the Board.
Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira oraz Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
IGC Pharma Inc executives and other stock owners filed with the SEC include: